CRH Medical Corp (TSE:CRH) had its price objective decreased by equities research analysts at Royal Bank Of Canada from C$8.50 to C$6.00 in a note issued to investors on Friday. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price suggests a potential upside of 47.42% from the stock’s previous close.

CRH has been the subject of a number of other reports. TD Securities reissued a “buy” rating and set a C$12.00 target price on shares of CRH Medical Corp in a research note on Friday, April 28th. National Bank Financial cut their target price on CRH Medical Corp from C$9.00 to C$7.00 in a research note on Monday. Bloom Burton downgraded CRH Medical Corp from a “buy” rating to an “accumulate” rating in a research note on Friday, July 14th. Finally, Scotiabank downgraded CRH Medical Corp from an “outperform” rating to a “sector perform” rating and cut their target price for the stock from C$10.00 to C$8.00 in a research note on Friday, July 14th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of C$7.75.

CRH Medical Corp (TSE:CRH) traded down 1.23% during mid-day trading on Friday, hitting $4.02. The stock had a trading volume of 490,196 shares. CRH Medical Corp has a 12-month low of $3.97 and a 12-month high of $12.35. The firm has a market cap of $297.15 million and a P/E ratio of 32.95. The stock has a 50-day moving average price of $6.98 and a 200 day moving average price of $8.66.

TRADEMARK VIOLATION WARNING: “CRH Medical Corp (CRH) Given New C$6.00 Price Target at Royal Bank Of Canada” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/07/21/crh-medical-corp-crh-given-new-c6-00-price-target-at-royal-bank-of-canada.html.

In related news, Director David Johnson sold 30,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of C$5.67, for a total value of C$170,100.00.

About CRH Medical Corp

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (TSE:CRH)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.